As of August 28, 2026, Cognition Therapeutics, Inc. (CGTX) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Cognition Therapeutics, Inc. has a market capitalization of $105.61M, 95.09M shares outstanding, 75 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 19%
🔄 Reverse Split
model est. 30%
• 50-day avg $1.11 approaching $1 threshold
🔁 Convertible Conversion
model 15%
• Convertible debt present: 11.8% potential dilution
Market Data
Market Cap$105.61M
Shares Outstanding95.09M
Float81.85M
Cash$34.01M
Debt$638.0K
Short InterestN/A
Institutional Holdings
QoQ: ↑ 4.7% shares (2026Q1 vs prior)
75 institutional holders · 24.65M shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
6.00M shares
#2
BIOS Capital Management, LP
6.00M shares
#3
DAVENPORT & Co LLC
2.89M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest8.93M
Days to Cover21.1
% of Float10.9%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2021-12-31
4
INSIDER TRANSACTION
2026-02-18
4
INSIDER TRANSACTION
2026-02-18
4
INSIDER TRANSACTION
2026-02-18
4
INSIDER TRANSACTION
2026-02-05
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual CGTX Dilution Snapshot
Cognition Therapeutics, Inc. (CGTX) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CGTX: 4 on 2026-02-18; 4 on 2026-02-18; 4 on 2026-02-18.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track CGTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CGTX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CGTX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.